DESTINY-Breast09 aims to bring Enhertu to the first-line metastatic setting with both monotherapy and pertuzumab combination ... are not fulfilled at the pharmacy level because still of access ...

Furthermore, in oncology, Perjeta/Phesgo conversion rate is now ... exchange rates and that was driven by a large specialty pharmacy order, which is very similar to the pattern that we've seen ...

I have one more round of TC to go before I start on four rounds of Perjeta and Herceptin ... was that I was told to walk over to a private pharmacy and order the drug, pay for it and then have ...

I have one more round of TC to go before I start on four rounds of Perjeta and Herceptin ... RM10,600 and what flummoxed me a little was that I was told to walk over to a private pharmacy and order ...

New Zealand women with ovarian cancer finally have funded access to bevacizumab. Pharmac’s announcement yesterday comes ten years after the treatment was funded in Australia, and follows a long ...

On February 2, 2025, Shanghai Henlius Biotech, Inc. (“Henlius”) announced FDA acceptance of the Biologics License Application (BLA) for HLX11, a proposed biosimilar to Genentech’s PERJETA.

blockade with trastuzumab and pertuzumab with the current standard of care, taxane plus trastuzumab and pertuzumab, in HER2-positive metastatic breast cancer (MBC). Compared with the taxane-based ...

Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe, and good evening to those listening in Asia. Welcome, ladies and gentlemen, to AstraZeneca's ...

The healthcare industry experienced a rollercoaster of a year in 2024, with pharmacy benefits undergoing significant shifts. Rising drug costs, advancements in medication technology, and changing ...

Despite the impact of the pandemic on cancer care, Perjeta grew 17% to CHF 2.9 billion ($3.2 billion) in the first nine months of 2020, now just fractionally behind Herceptin which declined 31% to ...

Breast Cancer commonly develops from the glandular tissues of the breast. Signs of breast cancer are lump in the breast, change in breast shape, dimpling of the skin, fluid coming from the nipple ...